Erythropoiesis-stimulating Agent

This page covers all Erythropoiesis-stimulating Agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Erythropoietin receptor, Erythropoietin receptor (EPOR), erythropoietin receptor.

Targets

Erythropoietin receptor · Erythropoietin receptor (EPOR) · erythropoietin receptor

Marketed (4)

• Epogen · Amgen · Metabolic · 400
  Epogen works by binding to the erythropoietin receptor, triggering a cascade of signals that stimulate the production of red blood cells.
• High dose erythropoietin · VA Office of Research and Development · Hematology
  High-dose erythropoietin stimulates erythroid progenitor cells in bone marrow to increase red blood cell production and hemoglobin levels.
• (F) RH-V14 · National Taiwan University Hospital · Hematology
  RH-V14 is a recombinant human erythropoietin used to stimulate erythropoiesis.
• Low dose erythropoietin · VA Office of Research and Development · Hematology
  Low-dose erythropoietin stimulates erythroid progenitor cells in the bone marrow to increase red blood cell production.

Phase 3 pipeline (7)

• r-HuEPO · Sunnybrook Health Sciences Centre · Oncology, Nephrology
  r-HuEPO is a recombinant form of human erythropoietin that stimulates red blood cell production.
• stable erythropoietin therapy · American Regent, Inc. · Hematology
  Stable erythropoietin therapy works by stimulating the production of red blood cells.
• US-licensed epoetin alfa · Sandoz · Oncology, Nephrology
  Epoetin alfa stimulates erythropoiesis by binding to the erythropoietin receptor.
• rhEPO · GlaxoSmithKline · Oncology
  rhEPO stimulates erythropoiesis by binding to the erythropoietin receptor.
• pegol-Sihematide · Jiangsu Hansoh Pharmaceutical Co., Ltd. · Hematology
  Pegol-sihematide is a long-acting erythropoiesis-stimulating agent that promotes red blood cell production.
• epoetin alfa or beta · Hoffmann-La Roche · Oncology
  Epoetin alfa and beta stimulate erythropoiesis by binding to the erythropoietin receptor.
• NESP · Genexine, Inc. · Nephrology
  NESP is a recombinant human erythropoietin analog that stimulates erythropoiesis.

Phase 2 pipeline (3)

• C.E.R.A. · Hoffmann-La Roche · Oncology
  C.E.R.A. is a continuous erythropoietin receptor activator.
• Epoetin biosimilar · Hospira, now a wholly owned subsidiary of Pfizer · Oncology
  Stimulates erythropoiesis by binding to the erythropoietin receptor
• Erythropoietin alpha · Mathew S. Maurer · Oncology
  Erythropoietin alpha stimulates erythropoiesis by binding to the erythropoietin receptor.

Phase 1 pipeline (1)

• A hydrogel containing erythropoietin · Remedor Biomed Ltd · Oncology
  Stimulates erythropoiesis by binding to and activating the erythropoietin receptor